Covetrus, Inc.

$20.99+0.00%(+$0.00)
TickerSpark Score
66/100
Solid
100
Valuation
45
Profitability
35
Growth
52
Health
100
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CVET research report →

52-Week Range97% of range
Low $13.39
Current $20.99
High $21.20

Companywww.covetrus.com

Covetrus, Inc. , together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers.

CEO
Benjamin Wolin
IPO
2019
Employees
4,035
HQ
Portland, ME, US

Price Chart

+8.03% · this period
$20.99$17.39$13.80Oct 13Apr 13Oct 12

Valuation

Market Cap
$0
P/E
-33.44
P/S
0.00
P/B
1.90
EV/EBITDA
4.82
Div Yield
0.00%

Profitability

Gross Margin
18.75%
Op Margin
-0.48%
Net Margin
-1.88%
ROE
-5.64%
ROIC
-0.80%

Growth & Income

Revenue
$4.58B · 5.44%
Net Income
$-86,000,000 · -352.63%
EPS
$-0.63 · -293.75%
Op Income
$-22,000,000
FCF YoY
940.00%

Performance & Tape

52W High
$21.20
52W Low
$13.39
50D MA
$20.87
200D MA
$18.85
Beta
1.51
Avg Volume
1.22M

Get TickerSpark's AI analysis on CVET

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Oct 13, 22CD&R Investment Associates IX, Ltd.other33,670,541
Oct 13, 22CD&R VFC Holdings L.P.other33,670,541
Oct 13, 22HELTON SANDRA Lsell14,638
Oct 13, 22LASKAWY PHILIP Asell38,727
Oct 13, 22Foulston Matthew J.sell53,075
Oct 13, 22ELLINGER DEBORAH Gsell14,638
Oct 13, 22Manoff Mark Jeffreysell14,638
Oct 13, 22Wolin Benjaminsell351,443
Oct 13, 22Kidd Rebecca Annsell51,093
Oct 13, 22Malenfant Matthewsell142,821

Our CVET Coverage

We haven't published any research on CVET yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate CVET Report →

Similar Companies